Jeff Conn (left), Ph.D., director of Vanderbilt University's program in Drug Discovery, sees a crisis in pharmaceuticals, in which business models and academic insularity don't mix. Read about here.
Subscribe to:
Post Comments (Atom)
Exploring innovation, investment and technologies
in Nashville, Tennessee, United States.
Please visit our website: VentureNashville.com
Jeff Conn (left), Ph.D., director of Vanderbilt University's program in Drug Discovery, sees a crisis in pharmaceuticals, in which business models and academic insularity don't mix. Read about here.
No comments:
Post a Comment